Table 2.
Baseline and posttest scores for fear of movement and secondary outcomes (N=16).
| Measure | Baseline | Posttest | Effect size (95% CI) | MCIDa, n (%) | |
| Kinesiophobia, mean (SD) | |||||
|
|
FDAQb | 59.20 (24.83) | 56.45 (21.02) | −0.15 (−0.55, 0.25) | 6 (38) |
|
|
POQ-VAc Fear | 12.44 (5.01) | 11.91 (3.01) | −0.10 (−0.69, 0.48) | N/Ad |
| Outliers excludede | |||||
|
|
FDAQ | 60.28 (25.31) | 54.75 (20.58) | −0.35 (−0.71, 0.01) | —f |
|
|
POQ-VA Fear | 12.31 (2.65) | 12.07 (4.95) | 0.06 (−0.47, 0.59) | — |
| Pain outcomes (POQ-VA), mean (SD) | |||||
|
|
Interfere daily living | 16.44 (12.36) | 17.33 (12.03) | 0.10 (−0.27, 0.47) | N/A |
|
|
Interfere mobility | 26.31 (9.58) | 22.25 (10.82) | −0.56 (−0.96, −0.16) | N/A |
|
|
Negative affect | 28.56 (10.96) | 29.09 (11.87) | 0.07 (−0.26, 0.40) | N/A |
| Numeric Rating Scale, mean (SD) | |||||
|
|
Pain intensity | 6.88 (1.26) | 6.38 (1.59) | −0.48 (−0.87, −0.10) | 1 (7) |
|
|
Outlier excluded | 6.73 (1.16) | 6.40 (1.64) | −0.40 (−0.69, −0.12) | — |
| PCSg | 28.83 (10.39) | 24.54 (15.45) | −0.41 (−0.79, −0.02) | 5 (36) | |
| PSFSh | 3.60 (1.59) | 5.98 (2.37) | 1.14 (0.50, 1.78) | 10 (67) | |
aMCID: minimum clinically important difference.
bFDAQ: Fear of Daily Activities Questionnaire.
cPOQ-VA: Pain Outcomes Questionnaire-VA.
dNot applicable.
eN=15.
fMCID not recalculated.
gPCS: Pain Catastrophizing Scale.
hPSFS: Patient-Specific Functioning Scale.